Titre : Récepteur facteur neurotrophique ciliaire

Récepteur facteur neurotrophique ciliaire : Questions médicales fréquentes

Termes MeSH sélectionnés :

Cholangitis
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Récepteur facteur neurotrophique ciliaire : Questions médicales les plus fréquentes", "headline": "Récepteur facteur neurotrophique ciliaire : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Récepteur facteur neurotrophique ciliaire : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-04-06", "dateModified": "2025-04-01", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Récepteur facteur neurotrophique ciliaire" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Récepteurs facteur croissance nerf", "url": "https://questionsmedicales.fr/mesh/D017475", "about": { "@type": "MedicalCondition", "name": "Récepteurs facteur croissance nerf", "code": { "@type": "MedicalCode", "code": "D017475", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.543.750.750.400.550" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Sous-unité alpha du récepteur du facteur neurotrophique ciliaire", "alternateName": "Ciliary Neurotrophic Factor Receptor alpha Subunit", "url": "https://questionsmedicales.fr/mesh/D053739", "about": { "@type": "MedicalCondition", "name": "Sous-unité alpha du récepteur du facteur neurotrophique ciliaire", "code": { "@type": "MedicalCode", "code": "D053739", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.543.750.750.400.550.250.249" } } }, { "@type": "MedicalWebPage", "name": "Récepteur gp130 de cytokines", "alternateName": "Cytokine Receptor gp130", "url": "https://questionsmedicales.fr/mesh/D050822", "about": { "@type": "MedicalCondition", "name": "Récepteur gp130 de cytokines", "code": { "@type": "MedicalCode", "code": "D050822", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.543.750.750.400.550.250.500" } } }, { "@type": "MedicalWebPage", "name": "Sous-unité alpha du récepteur au facteur d'inhibition de la leucémie", "alternateName": "Leukemia Inhibitory Factor Receptor alpha Subunit", "url": "https://questionsmedicales.fr/mesh/D053680", "about": { "@type": "MedicalCondition", "name": "Sous-unité alpha du récepteur au facteur d'inhibition de la leucémie", "code": { "@type": "MedicalCode", "code": "D053680", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.543.750.750.400.550.250.750" } } } ], "about": { "@type": "MedicalCondition", "name": "Récepteur facteur neurotrophique ciliaire", "alternateName": "Receptor, Ciliary Neurotrophic Factor", "code": { "@type": "MedicalCode", "code": "D020801", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Giovanni Tossetta", "url": "https://questionsmedicales.fr/author/Giovanni%20Tossetta", "affiliation": { "@type": "Organization", "name": "Department of Experimental and Clinical Medicine, Marche Polytechnic University, Ancona, Italy." } }, { "@type": "Person", "name": "Antonio Giordano", "url": "https://questionsmedicales.fr/author/Antonio%20Giordano", "affiliation": { "@type": "Organization", "name": "Department of Experimental and Clinical Medicine, Marche Polytechnic University, Ancona, Italy." } }, { "@type": "Person", "name": "Cuihong Jia", "url": "https://questionsmedicales.fr/author/Cuihong%20Jia", "affiliation": { "@type": "Organization", "name": "Department of Biomedical Sciences, Quillen College of Medicine, East Tennessee State University, Johnson City, TN, 37614, USA. Electronic address: jiac01@etsu.edu." } }, { "@type": "Person", "name": "Theo Hagg", "url": "https://questionsmedicales.fr/author/Theo%20Hagg", "affiliation": { "@type": "Organization", "name": "Department of Biomedical Sciences, Quillen College of Medicine, East Tennessee State University, Johnson City, TN, 37614, USA." } }, { "@type": "Person", "name": "Jessica Perugini", "url": "https://questionsmedicales.fr/author/Jessica%20Perugini", "affiliation": { "@type": "Organization", "name": "Department of Experimental and Clinical Medicine, Marche Polytechnic University, Ancona, Italy." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Influence of Frailty in Patients Undergoing Endoscopic Retrograde Cholangiopancreatography for Biliary Stone Disease: A Nationwide Study.", "datePublished": "2023-06-27", "url": "https://questionsmedicales.fr/article/37368202", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s10620-023-08013-0" } }, { "@type": "ScholarlyArticle", "name": "A case of hepaticojejunal anastomotic obstruction after a living-donor liver transplantation and recanalization using a high-frequency knife under the rendezvous technique.", "datePublished": "2023-05-11", "url": "https://questionsmedicales.fr/article/37170062", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s12328-023-01812-y" } }, { "@type": "ScholarlyArticle", "name": "Diseases of the Gallbladder and Biliary Tree.", "datePublished": "2023-04-18", "url": "https://questionsmedicales.fr/article/37516509", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.pop.2023.03.004" } }, { "@type": "ScholarlyArticle", "name": "Surgical outcomes after re-operation for excision of choledochal cyst with delayed biliary complications: A retrospective study on 40 patients.", "datePublished": "2023-02-07", "url": "https://questionsmedicales.fr/article/36792452", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.amjsurg.2023.02.004" } }, { "@type": "ScholarlyArticle", "name": "Endoscopic ultrasound-guided drainage using lumen-apposing metal stent of malignant afferent limb syndrome in patients with previous Whipple surgery: Multicenter study (with video).", "datePublished": "2022-05-31", "url": "https://questionsmedicales.fr/article/35429360", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/den.14330" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Acides aminés, peptides et protéines", "item": "https://questionsmedicales.fr/mesh/D000602" }, { "@type": "ListItem", "position": 3, "name": "Protéines", "item": "https://questionsmedicales.fr/mesh/D011506" }, { "@type": "ListItem", "position": 4, "name": "Protéines membranaires", "item": "https://questionsmedicales.fr/mesh/D008565" }, { "@type": "ListItem", "position": 5, "name": "Récepteurs de surface cellulaire", "item": "https://questionsmedicales.fr/mesh/D011956" }, { "@type": "ListItem", "position": 6, "name": "Récepteurs peptidiques", "item": "https://questionsmedicales.fr/mesh/D018000" }, { "@type": "ListItem", "position": 7, "name": "Récepteur facteur croissance", "item": "https://questionsmedicales.fr/mesh/D017978" }, { "@type": "ListItem", "position": 8, "name": "Récepteurs facteur croissance nerf", "item": "https://questionsmedicales.fr/mesh/D017475" }, { "@type": "ListItem", "position": 9, "name": "Récepteur facteur neurotrophique ciliaire", "item": "https://questionsmedicales.fr/mesh/D020801" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Récepteur facteur neurotrophique ciliaire - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Récepteur facteur neurotrophique ciliaire", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-16", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Récepteur facteur neurotrophique ciliaire", "description": "Comment diagnostiquer une dysfonction du récepteur CNTF ?\nQuels examens sont utilisés pour évaluer le récepteur CNTF ?\nY a-t-il des biomarqueurs pour le récepteur CNTF ?\nLe diagnostic nécessite-t-il une biopsie ?\nQuels symptômes peuvent indiquer un problème avec le CNTF ?", "url": "https://questionsmedicales.fr/mesh/D020801?mesh_terms=Cholangitis&page=11#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Récepteur facteur neurotrophique ciliaire", "description": "Quels sont les symptômes d'une déficience en CNTF ?\nLa douleur neuropathique est-elle liée au CNTF ?\nPeut-on observer des troubles moteurs avec le CNTF ?\nLes troubles sensoriels sont-ils associés au CNTF ?\nY a-t-il des signes cliniques spécifiques au CNTF ?", "url": "https://questionsmedicales.fr/mesh/D020801?mesh_terms=Cholangitis&page=11#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Récepteur facteur neurotrophique ciliaire", "description": "Peut-on prévenir les troubles liés au CNTF ?\nY a-t-il des mesures préventives spécifiques ?\nL'exercice régulier aide-t-il à prévenir les troubles du CNTF ?\nUne alimentation équilibrée peut-elle aider ?\nLe stress a-t-il un impact sur le CNTF ?", "url": "https://questionsmedicales.fr/mesh/D020801?mesh_terms=Cholangitis&page=11#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Récepteur facteur neurotrophique ciliaire", "description": "Quels traitements sont disponibles pour les troubles du CNTF ?\nLes thérapies géniques peuvent-elles aider le CNTF ?\nLes médicaments anti-inflammatoires sont-ils efficaces ?\nLa physiothérapie est-elle recommandée ?\nY a-t-il des traitements expérimentaux pour le CNTF ?", "url": "https://questionsmedicales.fr/mesh/D020801?mesh_terms=Cholangitis&page=11#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Récepteur facteur neurotrophique ciliaire", "description": "Quelles complications peuvent survenir avec le CNTF ?\nLe CNTF peut-il entraîner des troubles cognitifs ?\nY a-t-il un risque de dépendance aux médicaments ?\nLes complications sont-elles réversibles ?\nLe CNTF peut-il affecter la qualité de vie ?", "url": "https://questionsmedicales.fr/mesh/D020801?mesh_terms=Cholangitis&page=11#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Récepteur facteur neurotrophique ciliaire", "description": "Quels sont les facteurs de risque pour les troubles du CNTF ?\nL'âge est-il un facteur de risque pour le CNTF ?\nLe sexe influence-t-il le risque de troubles du CNTF ?\nLes infections peuvent-elles augmenter le risque ?\nLe mode de vie influence-t-il le risque de troubles ?", "url": "https://questionsmedicales.fr/mesh/D020801?mesh_terms=Cholangitis&page=11#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une dysfonction du récepteur CNTF ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur des tests neurologiques et des analyses génétiques." } }, { "@type": "Question", "name": "Quels examens sont utilisés pour évaluer le récepteur CNTF ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des IRM et des électromyogrammes peuvent être utilisés pour évaluer la fonction nerveuse." } }, { "@type": "Question", "name": "Y a-t-il des biomarqueurs pour le récepteur CNTF ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Actuellement, il n'existe pas de biomarqueurs spécifiques pour le récepteur CNTF." } }, { "@type": "Question", "name": "Le diagnostic nécessite-t-il une biopsie ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Une biopsie n'est généralement pas nécessaire pour diagnostiquer les troubles liés au CNTF." } }, { "@type": "Question", "name": "Quels symptômes peuvent indiquer un problème avec le CNTF ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes comme la faiblesse musculaire ou des douleurs neuropathiques peuvent indiquer un problème." } }, { "@type": "Question", "name": "Quels sont les symptômes d'une déficience en CNTF ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent faiblesse musculaire, douleurs chroniques et troubles sensoriels." } }, { "@type": "Question", "name": "La douleur neuropathique est-elle liée au CNTF ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le CNTF joue un rôle dans la modulation de la douleur neuropathique." } }, { "@type": "Question", "name": "Peut-on observer des troubles moteurs avec le CNTF ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des troubles moteurs peuvent survenir en raison d'une dysfonction du CNTF." } }, { "@type": "Question", "name": "Les troubles sensoriels sont-ils associés au CNTF ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des troubles sensoriels peuvent être observés en cas de dysfonction du CNTF." } }, { "@type": "Question", "name": "Y a-t-il des signes cliniques spécifiques au CNTF ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Des signes comme l'hypersensibilité ou l'engourdissement peuvent être spécifiques." } }, { "@type": "Question", "name": "Peut-on prévenir les troubles liés au CNTF ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "La prévention est difficile, mais un mode de vie sain peut réduire les risques." } }, { "@type": "Question", "name": "Y a-t-il des mesures préventives spécifiques ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Éviter les traumatismes nerveux et gérer les maladies chroniques peut aider." } }, { "@type": "Question", "name": "L'exercice régulier aide-t-il à prévenir les troubles du CNTF ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exercice régulier peut renforcer les muscles et améliorer la santé nerveuse." } }, { "@type": "Question", "name": "Une alimentation équilibrée peut-elle aider ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une alimentation riche en nutriments favorise la santé nerveuse et musculaire." } }, { "@type": "Question", "name": "Le stress a-t-il un impact sur le CNTF ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress chronique peut affecter la fonction nerveuse et aggraver les symptômes." } }, { "@type": "Question", "name": "Quels traitements sont disponibles pour les troubles du CNTF ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent des thérapies médicamenteuses et des interventions physiques." } }, { "@type": "Question", "name": "Les thérapies géniques peuvent-elles aider le CNTF ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Des recherches sont en cours sur l'utilisation de thérapies géniques pour cibler le CNTF." } }, { "@type": "Question", "name": "Les médicaments anti-inflammatoires sont-ils efficaces ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils peuvent réduire l'inflammation et améliorer les symptômes liés au CNTF." } }, { "@type": "Question", "name": "La physiothérapie est-elle recommandée ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la physiothérapie peut aider à améliorer la fonction musculaire et réduire la douleur." } }, { "@type": "Question", "name": "Y a-t-il des traitements expérimentaux pour le CNTF ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Des traitements expérimentaux, comme les thérapies biologiques, sont en cours d'évaluation." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec le CNTF ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications incluent la progression des troubles neurologiques et la douleur chronique." } }, { "@type": "Question", "name": "Le CNTF peut-il entraîner des troubles cognitifs ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des troubles cognitifs peuvent survenir en raison de la dysfonction du CNTF." } }, { "@type": "Question", "name": "Y a-t-il un risque de dépendance aux médicaments ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains traitements peuvent entraîner une dépendance, nécessitant une surveillance." } }, { "@type": "Question", "name": "Les complications sont-elles réversibles ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent être réversibles avec un traitement approprié." } }, { "@type": "Question", "name": "Le CNTF peut-il affecter la qualité de vie ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les troubles liés au CNTF peuvent significativement affecter la qualité de vie." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque pour les troubles du CNTF ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent des antécédents familiaux, des maladies auto-immunes et des traumatismes." } }, { "@type": "Question", "name": "L'âge est-il un facteur de risque pour le CNTF ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le risque de troubles liés au CNTF augmente avec l'âge." } }, { "@type": "Question", "name": "Le sexe influence-t-il le risque de troubles du CNTF ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines études montrent que le sexe peut influencer le risque de troubles." } }, { "@type": "Question", "name": "Les infections peuvent-elles augmenter le risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines infections peuvent déclencher des troubles liés au CNTF." } }, { "@type": "Question", "name": "Le mode de vie influence-t-il le risque de troubles ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un mode de vie sédentaire et une mauvaise alimentation augmentent le risque." } } ] } ] }

Sources (883 au total)

Influence of Frailty in Patients Undergoing Endoscopic Retrograde Cholangiopancreatography for Biliary Stone Disease: A Nationwide Study.

Pancreaticobiliary diseases are common in the elderly. To this end, frailty represents a state of vulnerability that should be considered when assessing the risks and benefits of therapeutic endoscopi... Using the National Readmissions Database, we identified patients with an admission diagnosis of cholangitis with obstructive stone from 2016 to 2019. Patients were determined to be of low frailty risk... During the study period, 5751 patients were identified with acute cholangitis with obstructing stone. Mean age of index admissions was 69.4 years and 51.8% were female. From the total cohort, 5119 (89... ERCP is not a risk factor for readmission among frail patients. However, frail patients are at higher risk for procedure-related complications, healthcare utilization, and mortality....

Surgical outcomes after re-operation for excision of choledochal cyst with delayed biliary complications: A retrospective study on 40 patients.

The purpose of this study is to review our experience in patients who underwent re-operation for delayed biliary complications after choledochal cyst (CDC) excision.... All the patients who underwent re-operation. for delayed biliary complications after CDC excision between August 2007 and July 2020 were included in this retrospective study. The outcomes of these pat... Of the total 40 patients with delayed biliary complications, 25 (62.5%) were female. Thirty-seven (92.5%) patients had a history of cholangitis. The median interval between CDC excision and the reoper... Surgery affords excellent results for majority of the patients with delayed biliary complications after CDC excision. Type IV cysts are more commonly associated with the development of delayed biliary...

Endoscopic ultrasound-guided drainage using lumen-apposing metal stent of malignant afferent limb syndrome in patients with previous Whipple surgery: Multicenter study (with video).

Endoscopic ultrasound-guided digestive anastomosis (EUS-A) is a new alternative under evaluation in patients presenting with afferent limb syndrome (ALS) after Whipple surgery. The aim of the present ... This is an observational multicenter study. All patients ≥18 years old with previous Whipple surgery presenting with ALS who underwent an EUS-A using a lumen-apposing metal stent (LAMS) between 2015 a... Forty-five patients (mean age: 65.5 ± 10.2 years; 44.4% male) were included. The most common underlying disease was pancreatic cancer (68.9%). EUS-A was performed at a median of 6 weeks after local tu... EUS-A is a safe and effective technique in the treatment of malignant ALS, achieving high clinical success with an acceptable recurrence rate....

Outcomes of double-layer continuous suture hepaticojejunostomy in pancreatoduodenectomy and total pancreatectomy.

This study aims to describe the technique and the results of double-layer continuous suture hepaticojejunostomy (HJ) following pancreatoduodenectomy (PD) and total pancreatectomy (TP).... A prospectively maintained database was analyzed retrospectively to identify incidence and severity of biliary leaks (BL) (ISGLS definition), as well as of HJ stenosis (HJS), cholangitis, and need for... BLs occurred in 5 patients (0.6%), including 2 (0.3%) combined pancreatic and biliary leaks. Rates of HJS, cholangitis, and need for redo-HJ were 6.1%, 5.4%, and 2.0%, respectively. Incidence of BL wa... Double layer continuous suture HJ is associated with low BL rates, and an acceptable incidence of late complications....

Overlap syndrome of primary biliary cholangitis and primary sclerosing cholangitis: two case reports.

Overlap syndrome between primary biliary cholangitis and primary sclerosing cholangitis is an extremely rare condition that has been reported in only few published cases so far in the literature. We h... We report two cases showing the manifestations of both primary biliary cholangitis and primary sclerosing cholangitis in two Tunisian female patients aged 74 and 42 years, respectively. The first case... Our cases raise awareness for this rare condition and indicate the importance of recognizing a possible overlap syndrome, especially in patients with primary biliary cholangitis, to optimize treatment...

Waiting for bile duct dilation before repair of bile duct injury: a worthwhile strategy?

Hepaticojejunostomy (HJ) is the gold standard procedure for repairing major bile duct injury (BDI). Dilation status of the BD before repair has not been assessed as a risk factor for anastomotic stric... This retrospective single-centre study was performed on a population of 87 patients with BDI repaired by HJ between 2007 and 2021. Dilation status was assessed preoperatively, and dilation was defined... Before final repair, the BDs were dilated (dBD) in 56.3% of patients and not dilated (ND) in 43.7%. Patients with ND at the time of repair had more severe BDI injury than those with dBD (94.7% vs. 77.... Dilation status of the BD before HJ for BDI seemed to have no impact on short- or long-term outcomes. Both surgical and radiological external biliary drainages after BDI appear to be acceptable option...

Comparison of metal versus plastic stent for preoperative biliary drainage in patients with pancreatic cancer undergoing neoadjuvant therapy: a meta-analysis and systematic review.

This study was performed to compare a metal stent (MS) and plastic stent (PS) in terms of efficacy and complications during neoadjuvant therapy (NAT) and the perioperative period.... We performed an electronic search of the following databases until 1 June 2022: PubMed, Embase, Web of Science, Cochrane Central Register of Controlled Trials, and ClinicalTrials.gov. Studies comparin... The meta-analysis showed that use of an MS was associated with lower rates of reintervention (p < 0.00001), delay of NAT (p = 0.007), recurrent biliary obstruction (RBO) (p = 0.003), and cholangitis (... Use of an MS for PBD in patients with pancreatic cancer undergoing NAT followed by surgery was associated with lower rates of reintervention, delay of NAT, RBO, and cholangitis compared with use of a ...